BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3905983)

  • 1. Use of influenza A virus vaccines in seronegative children: live cold-adapted versus inactivated whole virus.
    Feldman S; Wright PF; Webster RG; Roberson PK; Mahoney J; Thompson J; Doolittle M; Lott L; Johnson P; Christoph RC
    J Infect Dis; 1985 Dec; 152(6):1212-8. PubMed ID: 3905983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro production of anti-influenza virus antibody after simultaneous administration of H3N2 and H1N1 cold-adapted vaccines in seronegative children.
    Edwards KM; Snyder P; Thompson JM; Johnson PR; Wright PF
    Vaccine; 1986 Mar; 4(1):50-4. PubMed ID: 3962451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza Vaccine Investigators Group.
    Gruber WC; Belshe RB; King JC; Treanor JJ; Piedra PA; Wright PF; Reed GW; Anderson E; Newman F
    J Infect Dis; 1996 Jun; 173(6):1313-9. PubMed ID: 8648202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization of institutionalized asthmatic children and patients with psychomotor retardation using live attenuated cold-adapted reassortment influenza A H1N1, H3N2 and B vaccines.
    Miyazaki C; Nakayama M; Tanaka Y; Kusuhara K; Okada K; Tokugawa K; Ueda K; Shibata R; Nishima S; Yamane N
    Vaccine; 1993; 11(8):853-8. PubMed ID: 8356846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults.
    Sears SD; Clements ML; Betts RF; Maassab HF; Murphy BR; Snyder MH
    J Infect Dis; 1988 Dec; 158(6):1209-19. PubMed ID: 3198936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience.
    Neuzil KM; Dupont WD; Wright PF; Edwards KM
    Pediatr Infect Dis J; 2001 Aug; 20(8):733-40. PubMed ID: 11734733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial.
    Alexandrova GI; Budilovsky GN; Koval TA; Polezhaev FI; Garmashova LM; Ghendon YuZ ; Romanova YR; Smorodintsev AA
    Vaccine; 1986 Jun; 4(2):114-8. PubMed ID: 3524050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance of adults to challenge with influenza A wild-type virus after receiving live or inactivated virus vaccine.
    Clements ML; Betts RF; Tierney EL; Murphy BR
    J Clin Microbiol; 1986 Jan; 23(1):73-6. PubMed ID: 3700611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cold-adapted recombinant influenza A virus vaccines in seronegative young children.
    Wright PF; Okabe N; McKee KT; Maassab HF; Karzon DT
    J Infect Dis; 1982 Jul; 146(1):71-9. PubMed ID: 7045254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live attenuated influenza A virus vaccines in children: results of a field trial.
    Belshe RB; Van Voris LP; Bartram J; Crookshanks FK
    J Infect Dis; 1984 Dec; 150(6):834-40. PubMed ID: 6501927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults.
    Treanor JJ; Roth FK; Betts RF
    J Clin Microbiol; 1990 Mar; 28(3):596-9. PubMed ID: 2182673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease.
    Edwards KM; Dupont WD; Westrich MK; Plummer WD; Palmer PS; Wright PF
    J Infect Dis; 1994 Jan; 169(1):68-76. PubMed ID: 8277200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.
    Belshe RB; Mendelman PM; Treanor J; King J; Gruber WC; Piedra P; Bernstein DI; Hayden FG; Kotloff K; Zangwill K; Iacuzio D; Wolff M
    N Engl J Med; 1998 May; 338(20):1405-12. PubMed ID: 9580647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer.
    Carr S; Allison KJ; Van De Velde LA; Zhang K; English EY; Iverson A; Daw NC; Howard SC; Navid F; Rodriguez-Galindo C; Yang J; Adderson EE; McCullers JA; Flynn PM
    J Infect Dis; 2011 Nov; 204(10):1475-82. PubMed ID: 21949042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine.
    Johnson PR; Feldman S; Thompson JM; Mahoney JD; Wright PF
    J Infect Dis; 1986 Jul; 154(1):121-7. PubMed ID: 3711685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.
    Belshe RB; Gruber WC; Mendelman PM; Mehta HB; Mahmood K; Reisinger K; Treanor J; Zangwill K; Hayden FG; Bernstein DI; Kotloff K; King J; Piedra PA; Block SL; Yan L; Wolff M
    J Infect Dis; 2000 Mar; 181(3):1133-7. PubMed ID: 10720541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of live attenuated cold-adapted and avian-human influenza A/Bethesda/85 (H3N2) reassortant virus vaccines in infants and children.
    Steinhoff MC; Halsey NA; Wilson MH; Burns BA; Samorodin RK; Fries LF; Murphy BR; Clements ML
    J Infect Dis; 1990 Aug; 162(2):394-401. PubMed ID: 2197335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity.
    Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
    J Hyg (Lond); 1983 Jun; 90(3):351-9. PubMed ID: 6863909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live attenuated and inactivated influenza vaccine in school-age children.
    Gruber WC; Taber LH; Glezen WP; Clover RD; Abell TD; Demmler RW; Couch RB
    Am J Dis Child; 1990 May; 144(5):595-600. PubMed ID: 2330929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.